Simplify Logo

Full-Time

Senior Director

Global Pharmacovigilance & Risk Management, Medical Safety

Posted on 3/23/2024

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Develops treatments for infectious diseases

Biotechnology
Healthcare

Compensation Overview

$250k - $329kAnnually

+ Bonus + Equity

Senior, Expert

Remote in USA

This is a remote position; only supports employees within the United States.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Medical degree (MD/DO), PharmD, or equivalent required, with at least 2 years of experience in clinical/medical practice
  • 10+ years of related experience; experience in global pharma/biotech is preferred
  • Experience in authoring safety signal assessment reports, DSUR, PBRER, RMP, and RSI
  • Experience with signal detection process and managing safety information from clinical development and post-marketing sources
  • Experience leading cross-functional SRMTs teams.
  • Experience with global regulations and ICH guidance governing pharmacovigilance and risk management
  • Knowledge of drug development process, pharmacovigilance databases, and MedDRA coding
Responsibilities
  • Chair cross-functional Safety Risk Management Team (SRMT) to review safety data from all sources to detect, evaluate, monitor, and minimize safety signals/risks; to provide strategies for risk management/mitigation and develop Risk Tracking Document and RMP; to evaluate the Benefit-Risk profiles of Vir products
  • Contribute to safety related sections of clinical study documents including Study Protocols, Informed Consent Forms, IB Reference Safety Information, Publications, and other relevant documents
  • Provide expert guidance and leadership both internally and externally based on in-depth knowledge of development and post-marketing global regulations
  • Support inspection readiness and provide expertise in audits, inspections, and CAPAs
  • Perform medical review of Individual Case Safety Reports
  • Perform medical review and analysis for aggregate safety reports and responses to ad-hoc requests for safety information
  • Provide leadership in regulatory authority interactions regarding safety and risk management
  • Support the negotiation of safety data exchange/pharmacovigilance agreements with license partners and distributors for drug safety and risk management related activities
  • Assist in the maintenance of Global PVRM related cross-functional SOPs in compliance with global safety regulations and guidelines and lead corporate initiatives and inspection readiness

Vir Biotechnology is at the forefront of combating infectious diseases, leveraging advanced technologies such as a proprietary monoclonal antibody platform along with machine learning and artificial intelligence. This focus not only prioritizes public health but also fosters a culture of continuous innovation and commitment to scientific excellence. Working here means contributing to pivotal developments that address some of the most pressing global health challenges today, such as influenza, HIV, and COVID-19, in an environment that values cutting-edge research and a collaborative spirit.

Company Stage

Grant

Total Funding

$908.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

1%

1 year growth

2%

2 year growth

9%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent bullish quarterly reports and increased analyst estimates suggest strong financial performance.
  • Significant investments, such as the $214,000 from Diversified Trust Co, indicate confidence in Vir's future prospects.
  • Presentations at high-profile conferences like J.P. Morgan's Annual Healthcare Conference and AASLD's The Liver Meeting® enhance Vir's visibility and credibility in the biotech community.

What critics are saying

  • Recent layoffs and facility shutdowns indicate potential financial instability and operational challenges.
  • The resignation of key executives, including the CFO and Chief Medical Officer, could lead to strategic and leadership uncertainties.

What makes Vir Biotechnology unique

  • Vir Biotechnology's focus on leveraging immunology expertise to engineer human antibodies into powerful medicines sets it apart from competitors.
  • Their rapid growth, as evidenced by being ranked the fastest-growing company in North America on the 2023 Deloitte Technology Fast 500, highlights their market impact.
  • Vir's ongoing Phase 2 trials for chronic hepatitis delta and B demonstrate their commitment to addressing unmet medical needs with innovative therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement

INACTIVE